Michael Barbella, Managing Editor04.28.23
Exactech is touting the completion of hip resurfacing surgery using JointMedica's Polymotion hip implant, which is based on a metal-on-polyethylene articulation.
The surgery was performed by hip resurfacing specialist Jim MacKenzie, M.D., in Calgary, Canada, who is also celebrating a milestone accomplishment of 20 years of completing hip resurfacing procedures. The Polymotion hip implant addressed the unique pathology of the patient’s hip that could not be addressed with legacy, metal-on-metal hip resurfacing implants.
“Many patients benefit from hip resurfacing. Having performed this procedure for more than 20 years, it is exciting to see new developments in the hip resurfacing space. I look forward to being able to provide this technology for my patients,” MacKenzie said.
Exactech acquired a minority interest in JointMedica Limited last year. Both companies are collaborating to deliver the next generation of hip resurfacing to the global market through the Polymotion implant, which received Breakthrough Device Designation from the U.S. Food and Drug Administration in May 2022. The implant system will become available in targeted markets on a country-by-country basis following regulatory clearances.
“Historically, the concept of hip resurfacing has intellectually appealed to surgeons all over the world. In fact, Sir John Charnley, the credited inventor of the modern total hip replacement, intuitively performed hip resurfacing in his initial cohort of hip arthritis patients [rather than total hip arthroplasty]," Exactech Chief Strategy Officer Sharat Kusuma, M.D., said. "Sir Charnley’s early hip resurfacings failed due to inferior materials, not due to flaws in the procedure itself. Exactech is thrilled to now partner with the credited inventors of modern hip resurfacing, Derek McMinn M.D., FRCS, and Ronan Treacy, M.D., FRCS, and JointMedica, to deliver the next generation of metal-on-advanced-polyethylene hip resurfacing to the market.”
JointMedica is an orthopedic design and development “Think Tank,” intending to advance and disseminate new orthopedic implant concepts.
Exactech is a global medical device company that develops and markets orthopedic implant devices, related surgical instruments, and the Active Intelligence platform of smart technologies to hospitals and physicians. Headquartered in Gainesville, Fla., Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific.
The surgery was performed by hip resurfacing specialist Jim MacKenzie, M.D., in Calgary, Canada, who is also celebrating a milestone accomplishment of 20 years of completing hip resurfacing procedures. The Polymotion hip implant addressed the unique pathology of the patient’s hip that could not be addressed with legacy, metal-on-metal hip resurfacing implants.
“Many patients benefit from hip resurfacing. Having performed this procedure for more than 20 years, it is exciting to see new developments in the hip resurfacing space. I look forward to being able to provide this technology for my patients,” MacKenzie said.
Exactech acquired a minority interest in JointMedica Limited last year. Both companies are collaborating to deliver the next generation of hip resurfacing to the global market through the Polymotion implant, which received Breakthrough Device Designation from the U.S. Food and Drug Administration in May 2022. The implant system will become available in targeted markets on a country-by-country basis following regulatory clearances.
“Historically, the concept of hip resurfacing has intellectually appealed to surgeons all over the world. In fact, Sir John Charnley, the credited inventor of the modern total hip replacement, intuitively performed hip resurfacing in his initial cohort of hip arthritis patients [rather than total hip arthroplasty]," Exactech Chief Strategy Officer Sharat Kusuma, M.D., said. "Sir Charnley’s early hip resurfacings failed due to inferior materials, not due to flaws in the procedure itself. Exactech is thrilled to now partner with the credited inventors of modern hip resurfacing, Derek McMinn M.D., FRCS, and Ronan Treacy, M.D., FRCS, and JointMedica, to deliver the next generation of metal-on-advanced-polyethylene hip resurfacing to the market.”
JointMedica is an orthopedic design and development “Think Tank,” intending to advance and disseminate new orthopedic implant concepts.
Exactech is a global medical device company that develops and markets orthopedic implant devices, related surgical instruments, and the Active Intelligence platform of smart technologies to hospitals and physicians. Headquartered in Gainesville, Fla., Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific.